You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Clinical significance of diffusely increased splenic uptake on FDG-PET

Liu, Yiyan

Nuclear Medicine Communications:
doi: 10.1097/MNM.0b013e32832fa254
Review Article

Diffusely increased uptake is more commonly observed than focal uptake in the spleen on a whole-body [18F] fluorodeoxyglucose-positron emission tomography/computed tomography. The significance of diffusely increased splenic uptake varies in different clinical settings. On a pre-therapeutic scan for lymphoma, splenic uptake, greater than hepatic uptake, is a relative reliable indication of lymphomatous involvement of the spleen, unless the patient has a history of recent cytokine administration. In HIV infection, increased splenic uptake is usually noted in the early stage of the disease, which could reflect massive stimulation of B-cells in the spleen by nonreplicating antigenic material. Diffusely increased splenic uptake may also be present in sarcoidosis, malaria, and many inflammatory or hematopoietic diseases. Therapeutic-related reactive splenic uptake concurrent with bone marrow uptake is often secondary to administration of granulocyte colony-stimulating factor for myelosuppression or high-dose interferon-α-2b adjuvant therapy for melanoma.

Author Information

Nuclear Medicine Service, Department of Radiology, University Hospital, UMDNJ, Newark, New Jersey, USA

Correspondence to Yiyan Liu, MD, PhD, Nuclear Medicine, University Hospital, H-141, 150 Bergen Street, Newark, NJ 07103, USA

Tel: +1 973 972 6022; fax: +1 973 972 6954; e-mail:

Received 27 March 2009 Accepted 15 June 2009

© 2009 Lippincott Williams & Wilkins, Inc.